Latest News about LGVN
Recent news which mentions LGVN
European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods To Monitor Efficacy Of Lomecel-B™ Cell Therapy
August 26, 2022
Tickers
LGVN
From Benzinga
European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods to Monitor Efficacy of Lomecel-B™ Cell Therapy
August 26, 2022
Tickers
LGVN
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 24, 2022
From Benzinga
Earnings Scheduled For August 12, 2022
August 12, 2022
From Benzinga
Is This Company In A Special Position Even As The COVID-19 Pandemic Affects Cell-Based Therapy Industry?
August 09, 2022
From Benzinga
Publication Of Peer-Reviewed Study In Journal Of The Alzheimer's Association Could Mark A Significant Step For Longeveron
August 02, 2022
From Benzinga
Aging Veterans May Have New Options As VA And Longeveron Make Progress On Clinical Research Of Aging Frailty Treatment
July 28, 2022
From Benzinga
7 Moonshot Investments Upending a $10 Trillion Industry
July 08, 2022
From InvestorPlace
From Benzinga
This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session
July 07, 2022
From Benzinga
From Benzinga
A few trade ideas for the last week of June 2022
June 25, 2022
From AC Investor Blog
7 Ways to Prepare for a Recession: An Investor’s Guide
June 24, 2022
From InvestorPlace
Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It
June 15, 2022
From Benzinga
How to Buy Stocks in a Recession
May 16, 2022
From InvestorPlace
From Benzinga
Earnings Scheduled For May 13, 2022
May 13, 2022
From Benzinga
From InvestorPlace
From Benzinga
From InvestorPlace
71 Biggest Movers From Yesterday
April 27, 2022
From Benzinga
53 Biggest Movers From Yesterday
April 21, 2022
From Benzinga
Longeveron Partners With US Department Of Veterans Affairs For Its Phase 2 Alzheimer's Trial
April 18, 2022
Tickers
LGVN
From Benzinga
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
April 13, 2022
Tickers
LGVN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.